The Yamanaka factors, originally discovered in the context of stem cell research, consist of four genes: Oct4, Sox2, Klf4, and c-Myc. When introduced into somatic cells, these genes can effectively reset the cells to an embryonic-like state, allowing them to become any type of cell in the body. This reprogramming process has garnered interest in the field of geroscience, particularly for its potential applications in canine health and longevity. By restoring youthful characteristics to cells, researchers hope to combat age-related decline in various tissues and organs, which could lead to improved overall vitality for our dogs as they age. In the context of canine longevity, the implications of Yamanaka factors are particularly exciting. Aging in dogs, much like in humans, is associated with a gradual decline in cellular function, leading to various health issues such as decreased mobility, cognitive decline, and susceptibility to diseases. By exploring ways to harness the Yamanaka factors, scientists aim to develop therapies that could rejuvenate aging cells in dogs, potentially slowing down the aging process and enhancing quality of life. While this approach is still largely experimental, it represents a frontier in veterinary medicine that may provide new avenues for extending the healthy lifespan of our canine companions.